Jacob Evans is a seasoned Medical Writer at Envision Pharma Group since September 2019. Prior to this role, Jacob served as a Researcher PhD Student at the University of Sussex from February 2015 to January 2019, specializing in biochemistry with a focus on structural biology and biophysics related to protein interactions in the context of myeloid cell differentiation and acute myeloid leukaemia. Additionally, Jacob held the position of Doctoral Tutor, where responsibilities included running tutorials and seminars in human physiology, genetics, neuroscience, and lab skills in biochemistry, as well as supervising lab sessions and assessment marking. Jacob holds a Doctor of Philosophy (PhD) in Biochemistry, Structural Biology, and a Bachelor of Science (B.Sc.) in Biology, both from the University of Sussex.